Double-Blind, Crossover Design * |
Volunteer #'s |
Phase I |
Phase II |
# 1 thru # 6 |
b-Carotene+
placebo |
b-Carotene+
BioPerine® |
# 7 thru # 12 |
b-Carotene+
BioPerine® |
bb-Carotene+
placebo |
* Phase I & Phase II supplementation periods occurred 12 weeks apart.
Treatment |
Baseline |
Day 14 |
Change |
bb-Carotene+
placebo |
66.0 + 11.5 |
65.1 + 10.2 |
-0.9 + 2.4 |
b-Carotene+
BioPerine® |
65.2 + 11.9 |
65.0 + 10.6 |
-0.2 + 2.1 |
Comparisons (baseline vs. Day 14, placebo vs. BioPerine® at Day 14, placebo vs. BioPerine® change at Day 14) indicated no statistically significant differences. |
